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I think the study would benefit from the reporting of CEACs for the analyses from the perspective of the employee, the health sector, and from society. In case I would include the QALY gain. The CEACs can easily be generated by valuing the incremental QALY gain using the range of zero (or 20,000 Euros) to 80,000 Euros per QALY and plotting the proportion of bootstrap replicates generating a positive NMB for ECO across the range of values.
Minor points
The last sentence on P6 is unclear. I think you mean end of followup when you refer to drop-out in this context. Lines 31-32 on P7 should be '...to which all OPs were required to adhere.' Lines 46-48 on P8 are unclear. I think this refers to the value of time costs for the employee. Time was valued at 12.96 Euros for each hour of engagement by the employee in health care programmes which displaced domestic chores onto other members of the employee's family? Line 37 on P11. I think 'not statistically significant' is clearer terminology than 'statistically insignificant'. Line 7 on P14. You report that incremental net benefit from the employee's perspective is surrounded by uncertainty. In fact, the INB is highly significantly different from zero (p=0.001). Hence while there is uncertainty around the magnitude of the INB there is very little uncertainty regarding the cost-effective of the intervention from the employee's perspective. You report a number of results from various sensitivity analyses for the different perspectives. I think it would be very helpful to tabulate all the results in one table to allow ready comparison. You could tabule Net benefit with the 95% CIs in the same cell and columns for the different perspectives and a row for the base case and each of the sensitivity analyses. Line 31 on P15. 'Benefits largely stemmed from reduced absenteeism...' I would bullet the results from the societal persective in the principal findings section. Line 53 on P15. '...cost data are often non-normally distributed...' P16 You conclude as a limitation that there is much uncertainty in the results. I suspect that once the QALY gains are included and valued across the range of zero to 80,000 Euros there will be much less uncertainty.
Again, to reiterate my earlier point I don't think your analysis based on self reported absenteeism is conservative since it shows less uncertainty with regard to the likelihood the INB is positive than the analysis based on administrative data. First line on P17. '...were sick-listed for between 10 weeks and 2 years.' Line 38 on P17. You might want to clarify that the return on investment in Noben et al. was 11 Euros per Euro spent. Line 40 on P17. You refer to your own study as a preventive intervention -is this really what you meant?
REVIEWER
Kim Sweeny Victoria Institute of Strategic Economic Studies Victoria University Australia REVIEW RETURNED 22-Mar-2017
GENERAL COMMENTS
This is a well designed and executed piece of research in an area in which there are only a few other studies. It makes a solid contribution to the literature, especially as it presents estimates of returns on investment demonstrating the benefits of ECO under quite conservative assumptions. These estimates are in line with those for ROI in mental health and other areas of health.
Can I suggest that there be a short description of the role of the occupational physician in the Dutch health system and the difference between an OP and a primary care physician.
On a more substantive note there needs to be discussion of why the researchers obtained negative results for presenteeism in Tables 2  and 3 , especially in the light of the improvement in quality of life which would suggest that employees might be happier under ECO than CAU. Also the literature suggests that presenteeism is a larger problem than absenteeism in terms of economic costs so the authors might like to comment on this.
There are a few very minor grammatical mistakes which could be corrected in the final paper.
REVIEWER

William S. Shaw Liberty Mutual Research Institute for Safety
REVIEW RETURNED
27-Mar-2017
GENERAL COMMENTS
This manuscript describes a series of cost-benefit analyses for a cluster-randomized trial to improve return-to-work rates among sicklisted employees (n = 220) reporting depressive and anxious symptoms. The intervention consisted of a multi-module eHealth intervention ("Return@Work") based on cognitive-behavioral principles combined with encouragement and support from an occupational physician who received regular automated updates from the on-line training program. The primary outcome data sources were self-reported health care use and days absent from work, the EuroQOL-5D-3L, and the TiC-P, which included a number of direct and indirect non-medical costs including estimates of productivity loss while back at work.
An intention-to-treat analysis was used to compare intervention and usual care groups on total costs and cost savings. This was repeated using a variety of perspectives: employer, employee, health care payer, and overall societal perspective (considering all costs and cost savings). All outcomes were translated into Euros (including QALYs), and net benefits were estimated using bootstrapping techniques, and sensitivity analyses were conducted to assess the effect of missing data and outliers. The primary conclusion was a €3,187 advantage per employee from the employer perspective, a €3,537 advantage per employee at the societal level. However, confidence bands were large, and after trimming the 5% of cases with highest costs overall, the advantage from the societal perspective was €2,928 per employee. The authors conclude that the ECO intervention program offers good value for money for virtually all stakeholders, but wide confidence intervals require careful interpretation.
Long-term disability for mental health disorders is a large and growing problem in many countries, and more methods of intervention are needed to help facilitate a sustainable return to work for employees who are on prolonged sickness absence due to mental health symptoms. This manuscript provides a detailed costeffectiveness analyses for a cluster-randomized trial combining individual and provider-level approaches to improve coping and selfefficacy for returning to work. This is a low cost and highly feasible intervention strategy where even small individual gains may prove to be highly cost-effective when implemented on a large scale. Thus, this is an appropriate application of cost-benefit analyses that has potential relevance to a variety of stakeholders and policy-makers.
Overall, the authors should be congratulated for a very clear and concise presentation of their methodology and findings. The analytic strategy also has a number of strengths: analyzing cost savings from a variety of stakeholder perspectives, imputation of missing data using a variety of methods, and sensitivity analyses to remove extreme outliers. This reviewer finds only minor criticisms and suggestions:
1. Abstract/Settings: Recommend rewording for clarity: "Occupational health care in the Netherlands. Occupational physicians (n = 62) clustered and randomized by region into an experimental and a control group".
2. Abstract/Conclusions: The terminology "require careful interpretation" here in reference to confidence intervals is somewhat vague. What do these confidence intervals suggest about precision and generalizability of findings?
3. Methods/Participants (page 6): There should be some added rationale to explain why only employees from small and mediumsized companies were included and why the window of 4 to 26 weeks was chosen.
4. Methods/Participants (page 6): Some of the language in the manuscript implies that participating employees had a physiciandiagnosed mental health "disorder, " but this section states only that they self-reported a high level of depressive or anxious symptoms. It would be more accurate to use the terminology "common mental symptoms" rather than "common mental disorders" throughout the manuscript, as it"s unclear whether or not employees actually met the DSM criteria for mood or somatization disorders.
5. Methods/Procedure (page 6, line 5): This line seems to suggest that consenting participants were again randomized to the 2 conditions, but actually it was the patient"s provider who was randomized to one of the two groups. Please clarify wording.
6. Methods/Intervention (page 7, paragraph 2): The authors appropriately chose to follow an intent-to-treat analysis, but it would still be informative to know what level of dose was actually delivered for the eHealth intervention. To what extent did participants complete the modules? This has some relevance for interpretation of cost-savings.
7. Methods/Resource use and costing (page 8, paragraph 2): More details are needed to explain how questions on the TiC-P were translated into an estimate of productivity loss. The paper provides a thorough economic analysis of an online module designed to help employees on sick leave with mental health problems return to work. In general the analysis appears to be robust. The exclusion of health benefits in the analysis from the health sector perspective is puzzling. Advanced statistical techniques have been applied to quantify the impact of uncertainty on the results. The results of this analysis might most usefully be conveyed through the production of Costeffectiveness Acceptability Curves (CEACs) where the health benefits are included. The authors undertake analysis from four different perspectives: employee, employer, health care sector, and societal. Each is reported as a cost benefit analysis. However, the health benefits of the intervention are only included in the analysis from the employee's perspective. It's difficult to see why the health benefits would be excluded from analysis taking either a health sector perspective or a societal perspective. In my view both analyses should include the health benefits. Such analysis might be considered a cost-benefit analysis if the health benefits are monetised. In fact the health benefits are measured in QALYs and a conservative value of 20,000 Euros per QALY is assumed. In my view it would be more correct to consider this a cost-utility analysis. Simply monetising QALY gains at 20,000 Euros does not convey the impact of different values one might place on a QALY gain on the results of the analysis. It would be more useful to decision makers to provide the results as a CEAC in which the likelihood the intervention is cost-effective is conveyed as a function of the value placed on a unit gain in health (QALY). The analysis from the employer's perspective excludes health benefits which seems reasonable. I would regard the impact of presenteeism and absenteeism as a cost (averted) and not a benefit of the intervention. This is perhaps a semantic point but this renders this analysis a cost-minimisation analysis. Nothing wrong with that, but I don't think the analysis from the employer's perspective is a true CBA. The authors are to be commended in their use of robust techniques to deal with the missing data alongside bootstrapping to capture the sampling uncertainty. A little more methodological detail would be useful. Did the authors bootstrap prior to fitting the EM models? There was one aspect of the analysis that troubled me. The authors choose to use self-reported data for absence rather than administrative records. They acknowledge substantial differences between the two sources. Why make the self-report data the base case? Surely the administrative records are more accurate? The authors justify this on the grounds that the self-report figures are lower generating a more conservative analysis. However, the analysis using the administrative data generates greater uncertainty (higher p-values). Hence one might regard the analysis based on administrative data as more conservative. I think the study would benefit from the reporting of CEACs for the analyses from the perspective of the employee, the health sector, and from society. In case I would include the QALY gain. The CEACs can easily be generated by valuing the incremental QALY gain using the range of zero (or 20,000 Euros) to 80,000 Euros per QALY and plotting the proportion of bootstrap replicates generating a positive NMB for ECO across the range of values.
Comment 1. It's difficult to see why the health benefits would be excluded from analysis taking either a health sector perspective or a societal perspective.
REPLY: We do understand that excluding health benefits (the economic value that could be placed on gaining one QALY) in a health-economic analysis is puzzling when taking the health care perspective. However, these analyses were conducted from a "health care payer"s perspective" (in the Dutch context: the perspective of health care insurance companies). Had we used the health care sector perspective then we"d have fully agreed with the reviewer that the inclusion of health benefits would have been appropriate. However, in this study we conducted an investment appraisal from different stakeholders" perspectives. In this context, we did not compute the net-benefits from a general health care sector perspective, but specifically from the perspective of the health care insurer. In our opinion QALY gains do not directly benefit a health care insurer. To drive this point home, we consistently used the phrase health care payer"s perspective, which in the Dutch context is the same as saying the health care insurance perspective.
That said, we agree with the reviewer that it is consistent to include the QALY gains into the analysis that were conducted from the societal perspective, instead of merely focussing on hard outcomes such as tangible Euros. To that end, we conducted extra analyses and replaced the outcomes of the societal perspective with the new values that now include the monetary value of gaining QALYs.
Comment 2. In my view it would be more correct to consider this a cost-utility analysis. Simply monetising QALY gains at 20,000 Euros does not convey the impact of different values one might place on a QALY gain on the results of the analysis. It would be more useful to decision makers to provide the results as a CEAC in which the likelihood the intervention is cost-effective is conveyed as a function of the value placed on a unit gain in health (QALY).
REPLY: We thank the reviewer for his remark. In our analyses we made investment appraisals from the stakeholder"s perspectives. We included QALY gains, but only in our analysis from the employee/patient perspective (and the all encompassing societal perspective), and not in other perspectives, such as the employer"s perspective. Hence we cannot find a justification in calling our investment appraisal a cost-utility analysis. We prefer to compute benefits under conservative assumptions. If we place too much value on the QALY gains (i.e. €50,000 or €80,000) then we would probably portray a too rosy picture, even to the point where the QALY gains will dominate the outcomes of the investment appraisals.
Comment 3. I would regard the impact of presenteeism and absenteeism as a cost (averted) and not a benefit of the intervention. This is perhaps a semantic point but this renders this analysis a costminimisation analysis REPLY: We disagree politely. In a cost-minimisation analysis two interventions are compared that are (assumed to be) equally effective and one simply choses the intervention that is associated with the fewest costs. However, the ECO-intervention in our study is more effective than care as usual and our health-economic evaluation was conducted alongside a superiority trial (not a non-inferiority trial).
Comment 4. A little more methodological detail would be useful. Did the authors bootstrap prior to fitting the EM models?
REPLY: We conducted non-parametric bootstrapping after fitting the EM models. We clarified this in the "analyses" section (page 10).
Comment 5. Why make the self-report data the base case? Surely the administrative records are more accurate? The authors justify this on the grounds that the self-report figures are lower generating a more conservative analysis. However, the analysis using the administrative data generates greater uncertainty (higher p-values). Hence one might regard the analysis based on administrative data as more conservative.
REPLY: We agree with the reviewer that administrative data about absenteeism are likely to be more accurate than self-reported data. However, we did not have access to administrative data for absenteeism 3, 6 and 9 months after baseline, only for the period of one calendar year. Please note, the administrative data that were based on one-year periods are not helpful for constructing fine graded cash flows (in one-month cycles) that were required for our return on investment analyses. An additional advantage of the self-reported data over the administrative data was that data about presenteeism were only available from self-reports and we preferred to base the analyses of absenteeism and presenteeism on the same data source.
MINOR POINTS Comment 1. The last sentence on P6 is unclear. I think you mean end of follow-up when you refer to drop-out in this context.
REPLY:
We thank the reviewer for pointing out the lack of clarity. We clarified the last sentence of the "procedure" section of the revised manuscript (page 6, line 35-36).
Comment 2. Lines 31-32 on P7 should be '...to which all OPs were required to adhere.' REPLY: We thank the reviewer for the comment. The sentence has been corrected in the revised manuscript accordingly (page 7, line 22).
Comment 3. Lines 46-48 on P8 are unclear. I think this refers to the value of time costs for the employee. Time was valued at 12.96 Euros for each hour of engagement by the employee in health care programmes which displaced domestic chores onto other members of the employee's family?
REPLY: These costs refer to the number of hours that (informal) caregivers spent on taking over cleaning activities and running domestic errands. We rephrased the lines in the manuscript to clarify the meaning of these costs (page 8, lines 31-33).
Comment 4. Line 37 on P11. I think 'not statistically significant' is clearer terminology than 'statistically insignificant'.
REPLY: We changed the sentence in the manuscript accordingly (page 11, line 7).
Comment 5. Line 7 on P14. You report that incremental net benefit from the employee's perspective is surrounded by uncertainty. In fact, the INB is highly significantly different from zero (p=0.001). Hence while there is uncertainty around the magnitude of the INB there is very little uncertainty regarding the cost-effectiveness of the intervention from the employee's perspective.
REPLY: The reviewer correctly noticed that there is no uncertainty about the significance of the INB from the employee"s perspective, but only about the magnitude of the INB. We rephrased this sentence accordingly (page 14). REPLY: We thank the reviewer for pointing the grammatical error to us. We corrected it in the revised manuscript accordingly (page 15, line 28).
Comment 8. I would bullet the results from the societal perspective in the principal findings section.
REPLY: As suggested by the reviewer we bulleted the results from the societal perspective in the "principal findings" section in the manuscript (page 16).
Comment 9. Line 53 on P15. '...cost data are often non-normally distributed...' REPLY: We thank the reviewer and corrected the typo in the revised manuscript.
Comment 10. P16 You conclude as a limitation that there is much uncertainty in the results. I suspect that once the QALY gains are included and valued across the range of zero to 80,000 Euros there will be much less uncertainty.
REPLY: As indicated in an earlier remark, we did not place a higher monetary value than €20,000 on gaining one QALY. In doing so we adhere to the Dutch guideline for costing in health-economic evaluations and present results that were computed under conservative assumptions.
Comment 11. Again, to reiterate my earlier point I don't think your analysis based on self reported absenteeism is conservative since it shows less uncertainty with regard to the likelihood the INB is positive than the analysis based on administrative data.
REPLY: We agree with the reviewer that the uncertainty of the INB being positive is larger in the analysis based on the administrative data. What we tried to explain is that the analysis based on selfreported data shows a lower point estimate for the INB from a societal perspective than the analysis based on administrative data. We changed the sentence about uncertainty in the manuscript for greater clarity (page 14, line 31). This is a well-designed and executed piece of research in an area in which there are only a few other studies. It makes a solid contribution to the literature, especially as it presents estimates of returns on investment demonstrating the benefits of ECO under quite conservative assumptions. These estimates are in line with those for ROI in mental health and other areas of health. Comment 1. Can I suggest that there be a short description of the role of the occupational physician in the Dutch health system and the difference between an OP and a primary care physician REPLY: We thank the reviewer the suggestion and we added a description of the OPs role in the Dutch health care system to the introduction of the revised manuscript (page 4).
Comment 2. On a more substantive note there needs to be discussion of why the researchers obtained negative results for presenteeism in Tables 2 and 3 , especially in the light of the improvement in quality of life which would suggest that employees might be happier under ECO than CAU. Also the literature suggests that presenteeism is a larger problem than absenteeism in terms of economic costs so the authors might like to comment on this.
REPLY: The reviewer raises interesting points and we agree that attention should be paid in the discussion to why we obtained negative results for presenteeism (in the short-run, but not in the longrun) and why in our study absenteeism was a larger problem than presenteeism. We have added possible explanations to the Discussion: "However, other than Noben and colleagues and several other studies we found negative results for presenteeism in the short run (first nine months), but these were alleviated in the longer run (at the end of the year). An explanation for the initially negative results on presenteeism might be that employees who returned to work early were not completely fit and as productive as normally. In other words there was an initial trade-off between reduced absenteeism and increased presenteeism. However, after the first nine months the additional costs caused by presenteeism ceased to exist and were reversed into benefits. This change is possibly driven by an improvement in quality of life when people work."
"The literature suggests that in terms of economic costs presenteeism is a larger problem than absenteeism. Our results are not in line with these findings. This could be due to the Dutch system in which employees receive a substantial percentage of their wage during the first two years of their illness. In many other countries the fall in income is more acute when employees stay absent from their work, increasing the incentive to keep on working -even when work is then associated with greater levels of presenteeism."
Comment 3. There are a few very minor grammatical mistakes which could be corrected in the final paper.
REPLY: We thank the reviewer for the remark. We corrected typos and grammatical mistakes in the manuscript. This manuscript describes a series of cost-benefit analyses for a cluster-randomized trial to improve return-to-work rates among sick-listed employees (n = 220) reporting depressive and anxious symptoms. The intervention consisted of a multi-module eHealth intervention ("Return@Work") based on cognitive-behavioral principles combined with encouragement and support from an occupational physician who received regular automated updates from the on-line training program. The primary outcome data sources were self-reported health care use and days absent from work, the EuroQOL-5D-3L, and the TiC-P, which included a number of direct and indirect non-medical costs including estimates of productivity loss while back at work. An intention-to-treat analysis was used to compare intervention and usual care groups on total costs and cost savings. This was repeated using a variety of perspectives: employer, employee, health care payer, and overall societal perspective (considering all costs and cost savings). All outcomes were translated into Euros (including QALYs), and net benefits were estimated using bootstrapping techniques, and sensitivity analyses were conducted to assess the effect of missing data and outliers. The primary conclusion was a €3,187 advantage per employee from the employer perspective, a €3,537 advantage per employee at the societal level. However, confidence bands were large, and after trimming the 5% of cases with highest costs overall, the advantage from the societal perspective was €2,928 per employee. The authors conclude that the ECO intervention program offers good value for money for virtually all stakeholders, but wide confidence intervals require careful interpretation.
REVIEWER: 3
Long-term disability for mental health disorders is a large and growing problem in many countries, and more methods of intervention are needed to help facilitate a sustainable return to work for employees who are on prolonged sickness absence due to mental health symptoms. This manuscript provides a detailed cost-effectiveness analyses for a cluster-randomized trial combining individual and providerlevel approaches to improve coping and self-efficacy for returning to work. This is a low cost and highly feasible intervention strategy where even small individual gains may prove to be highly cost-effective when implemented on a large scale. Thus, this is an appropriate application of cost-benefit analyses that has potential relevance to a variety of stakeholders and policy-makers.
Overall, the authors should be congratulated for a very clear and concise presentation of their methodology and findings. The analytic strategy also has a number of strengths: analyzing cost savings from a variety of stakeholder perspectives, imputation of missing data using a variety of methods, and sensitivity analyses to remove extreme outliers. This reviewer finds only minor criticisms and suggestions: Comment 1. Abstract/Settings: Recommend rewording for clarity: "Occupational health care in the Netherlands. Occupational physicians (n = 62) clustered and randomized by region into an experimental and a control group".
REPLY: We thank the reviewer for the recommendation and clarified the sentence in the manuscript as suggested (page 3).
Comment 2. Abstract/Conclusions: The terminology "require careful interpretation" here in reference to confidence intervals is somewhat vague. What do these confidence intervals suggest about precision and generalizability of findings?
REPLY: We rephrased the sentence and now say: "the sometimes wide 95% confidence intervals suggest that the costs and benefits are not always very precise estimates and real benefits could vary considerably." (page 3).
Comment 3. Methods/Participants (page 6): There should be some added rationale to explain why only employees from small and medium-sized companies were included and why the window of 4 to 26 weeks was chosen.
REPLY: There was a minimum of 4 weeks of sickness absence to avoid including patients with "spontaneous" recovery. A maximum of 26 weeks of sickness absence duration was chosen because the probability of return to work reduces in case of longer absence (Henderson, 2005) . The choice for small and medium-sized companies was made for practical reasons. The study was conducted in collaboration with Arbo Vitale and GGzBreburg. Arbo Vitale is a large occupational health service, offering employers insurance for the costs of sick leave and sickness guidance. Arbo Vitale observed a lot of costs due to absenteeism among employees of small-sized to medium-sized companies, which was the rationale to focus on this target group in the study.
Comment 4. Methods/Participants (page 6): Some of the language in the manuscript implies that participating employees had a physician-diagnosed mental health "disorder, " but this section states only that they self-reported a high level of depressive or anxious symptoms. It would be more accurate to use the terminology "common mental symptoms" rather than "common mental disorders" throughout the manuscript, as it"s unclear whether or not employees actually met the DSM criteria for mood or somatization disorders.
Hence, it is most likely that the majority of the participants did have a disorder, but the reviewer is right that we cannot be 100% sure if they were meeting the diagnostic criteria for DSM disorders. Therefore, we changed "common mental disorder" into "(symptoms of) common mental disorder".
Comment 5. Methods/Procedure (page 6, line 5): This line seems to suggest that consenting participants were again randomized to the 2 conditions, but actually it was the patient"s provider who was randomized to one of the two groups. Please clarify wording.
REPLY: We thank the reviewer for pointing this out. We rephrased the sentence in the "procedure" section on page 6 of the manuscript to clarify.
Comment 6. Methods/Intervention (page 7, paragraph 2): The authors appropriately chose to follow an intent-to-treat analysis, but it would still be informative to know what level of dose was actually delivered for the eHealth intervention. To what extent did participants complete the modules? This has some relevance for interpretation of cost-savings.
REPLY: We added a description about the intervention adherence of the ECO intervention by the employees to the revised manuscript (page 11).
Comment 7. Methods/Resource use and costing (page 8, paragraph 2): More details are needed to explain how questions on the TiC-P were translated into an estimate of productivity loss.
REPLY: As indicated in the manuscript, days not worked owing to absenteeism were costed using the average gross gender-and age-specific daily wages (as per the Dutch guideline for costing in healtheconomic evaluations). For presenteeism we took a similar approach, but days not worked were now estimated by multiplying a self-reported inefficiency score (ranging between 0 and 1) with the number of days worked inefficiently. To illustrate, if an employee reports and inefficiency score of 0.50 for 7 working days then we assume that 3.5 working days have been lost due to inefficiency. We added this illustration to the manuscript (page 9, lines 9-10).
Comment 8. Discussion (page 18, paragraph 1): A more detailed discussion is needed to interpret the wide confidence intervals from the study. What does this mean in terms of generalizability of results, and how can this lack of precision be dealt with in future studies of this type?
REPLY: As noted, some 95% confidence intervals of the net-benefits are wide. By implication, one should not rely too much on the point estimates of net-benefits, return on investment ratios, breakeven points, because they lack precision. In other words, our estimates, although conservative, have some degree of uncertainty and are therefore no substitute for one"s own business judgement.
